{{Distinguish|fluconazole}}
{{multiple issues|
{{context|date=October 2016}}
{{refimprove|date=October 2016}}
}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458449795
| IUPAC_name = ''S''-Fluoromethyl (6''S'',8''S'',9''R'',10''S'',11''S'',13''S'',14''S'',16''R'',17''R'')-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[''a'']phenanthrene-17-carbothioate
| image = Fluticasone.svg

<!--Clinical data-->
| tradename =  Cutivate
| Drugs.com = {{drugs.com|monograph|flovent}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = C for Intranasal and Inhaled
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = Rx-only <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_US = OTC
| legal_US_comment = (intranasal as the propionate), Rx-only (other preparations including furoate and base intranasal)
| routes_of_administration = Intranasal, inhaled, topical cream or ointment

<!--Pharmacokinetic data-->
| bioavailability = 0.51% (Intranasal)
| protein_bound = 91%
| metabolism = Intranasal<br />[[Liver|Hepatic]] ([[CYP3A4]]-mediated)
| elimination_half-life = 10 hours
| excretion = [[Kidney|Renal]]

<!--Identifiers-->
| IUPHAR_ligand = 6699
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 90566-53-3
| ATC_prefix = D07
| ATC_suffix = AC17
| ATC_supplemental = {{ATC|R01|AD08}} {{ATC|R03|BA05}}
| PubChem = 5311101
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
 | DrugBank = DB00588
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4470631
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = CUT2W21N7U
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07981
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 5134
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201396

<!--Chemical data-->
 | C=22 | H=27 | F=3 | O=4 | S=1 
| molecular_weight = 444.508 g/mol
| smiles = O=C(SCF)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)[C@@H](F)C[C@H]4[C@@H]2C[C@H]3C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MGNNYOODZCAHBA-GQKYHHCASA-N
| synonyms = 6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-21-thia-21-fluoromethylpregna-1,4-dien-3,20-dione
}}

'''Fluticasone''' is a synthetic [[glucocorticoid]].<ref name="Briggs_et_al2012" /> Both the [[furoate]] and [[propanoate]] [[ester]]<nowiki/>s, [[fluticasone furoate]] and [[fluticasone propionate]], are used as topical [[Anti-inflammatory|anti-inflammatories]]<ref name="SprattoWoods2012" /> and inhaled [[corticosteroids]].

==References==
{{Reflist|refs=
<ref name="Briggs_et_al2012">{{Citation
 | last1     = Briggs
 | first1    = Gerald G.
 | last2     = Freeman
 | first2    = Roger K.
 | last3     = Yaffe
 | first3    = Sumner J.
 | title     = Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
 | publisher = Lippincott Williams & Wilkins
 | page      = 600
 | year      = 2012
 | isbn      = 1451153597
 | url       = https://books.google.com/books?id=ScPvM03B3lUC&pg=PA600
 | postscript= .
}}</ref>
<ref name="SprattoWoods2012">{{Citation
 | last1     = Spratto
 | first1    = George R.
 | last2     = Woods
 | first2    = Adrienne L.
 | title     = Delmar Nurse's Drug Handbook 2012
 | publisher = Cengage Learning
 | page      = 748
 | year      = 2012
 | isbn      = 1111310653
 | url       = https://books.google.com/books?id=x-f-kedg9ukC&pg=PA748
 | postscript= .
}}</ref>
}}

{{Glucocorticoids}}
{{Nasal preparations}}
{{Asthma and copd_rx}}
{{Glucocorticoidics}}
{{GlaxoSmithKline}}

[[Category:Antiasthmatic drugs]]
[[Category:Drugs acting on the respiratory system]]
[[Category:Glucocorticoids]]
[[Category:Organofluorides]]
[[Category:Respiratory therapy]]